Chen Y, et al. investigated the therapeutic effects of hepatocyte growth factor (HGF) modified UC-MSCs in ischemia/reperfusion-induced AKI rat models, and the results indicated that the HGF modification could promote the amelioration of ischemia/reperfusion- induced rat renal injury via anti-apoptotic and anti-inflammatory mechanisms19. Here, HGF is linked to ischemia.